Synonym
GFH009; GFH 009; GFH-009
IUPAC/Chemical Name
4-(((4-(5-chloro-2-(((1R,4r)-4-(((R)-1-methoxypropan-2-yl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile
InChi Key
PGVNLOUNSPQGJP-GUDVDZBRSA-N
InChi Code
InChI=1S/C25H35ClN6O2S/c1-17(13-33-2)30-18-3-5-19(6-4-18)31-23-11-20(21(26)12-28-23)22-14-35-24(32-22)29-16-25(15-27)7-9-34-10-8-25/h11-12,14,17-19,30H,3-10,13,16H2,1-2H3,(H,28,31)(H,29,32)/t17-,18-,19-/m1/s1
SMILES Code
COC[C@@H](C)N[C@@H]1CC[C@@H](NC2=NC=C(Cl)C(C3=CSC(NCC4(C#N)CCOCC4)=N3)=C2)CC1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
519.11
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Zhou F, Tang L, Le S, Ge M, Cicic D, Xie F, Ren J, Lan J, Lu Q. The
pharmacodynamic and mechanistic foundation for the antineoplastic effects of
GFH009, a potent and highly selective CDK9 inhibitor for the treatment of
hematologic malignancies. Oncotarget. 2023 Dec 20;14:997-1008. doi:
10.18632/oncotarget.28543. PMID: 38117531; PMCID: PMC10732257.
2: Wang L, Zhao JZ, Zhou FS, Lan J, Lu Q, Ren HC. Preclinical metabolism and
disposition of [14C]GFH009, a novel selective CDK9 inhibitor.
Xenobiotica. 2024 Oct;54(10):831-839. doi: 10.1080/00498254.2024.2428716. Epub
2024 Nov 15. PMID: 39526731.
3: Liu Q, Zhao JZ, Zhou FS, Lan J, Lu Q, Ren HC. Development and validation of a
sensitive UPLC-MS/MS analytical method for GFH009 in rat plasma and its
application to toxicokinetics studies. Biomed Chromatogr. 2024 Feb;38(2):e5788.
doi: 10.1002/bmc.5788. Epub 2023 Dec 11. PMID: 38081587.